Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • nct (2)
Country
  • Canada (2)
  • Czech Republic (2)
  • France (2)
  • Germany (2)
  • Hungary (2)
  • Netherlands (2)
  • Poland (2)
  • Russian Federation (2)
  • Spain (2)
  • United States (2)
  • Argentina (1)
  • Austria (1)
  • Belgium (1)
  • Bulgaria (1)
  • Colombia (1)
  • Denmark (1)
  • Finland (1)
  • Israel (1)
  • Italy (1)
  • Korea, Republic of (1)
  • Mexico (1)
  • Romania (1)
  • Serbia (1)
  • Sweden (1)
  • Switzerland (1)
  • Ukraine (1)
  • United Kingdom (1)
Source
  • nct (2)
Phase
  • ongoing (2)

Country: Russian Federation,Czech Republic,Spain - Phase: ongoing
nct Update Il y a 5 ans

Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis This study is an extension to the study AC-058B201 and will investigate the long-term safety, tolerability and efficacy of ponesimod in patients with relapsing-remitting multiple sclerosis.

  • Country Austria, Bulgaria, Canada, Czech Republic, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information
nct Update Il y a 5 ans

A Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids This study is being conducted in patients taking glucocorticoids for treatment of various diseases. It is a 2-year study that will compare the effects of denosumab and risedronate.

  • Country Argentina, Belgium, Canada, Colombia, Czech Republic, Denmark, France, Germany, Hungary, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Spain, United States,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.